Letter re: A critical appraisal of the DATA trial analysis on the prognostic and predictive value of the luminal-like subtype.
作者信息
Rizk M, Mokbel K
机构信息
The London Breast Institute, Princess Grace Hospital, London, UK.
The London Breast Institute, Princess Grace Hospital, London, UK.
出版信息
ESMO Open. 2025 May;10(5):105067. doi: 10.1016/j.esmoop.2025.105067. Epub 2025 Apr 15.
Abstract
摘要
相似文献
1
Letter re: A critical appraisal of the DATA trial analysis on the prognostic and predictive value of the luminal-like subtype.关于《 luminal样亚型的预后和预测价值的DATA试验分析的批判性评价》的信件
ESMO Open. 2025 May;10(5):105067. doi: 10.1016/j.esmoop.2025.105067. Epub 2025 Apr 15.
2
Response to letter: a critical appraisal of the DATA trial analysis on the prognostic and predictive value of the luminal-like subtype.对信件的回复：对腔面样亚型的预后和预测价值的DATA试验分析的批判性评估。
ESMO Open. 2025 May;10(5):105070. doi: 10.1016/j.esmoop.2025.105070. Epub 2025 Apr 15.
3
Letter re: The prognostic and predictive value of the luminal-like subtype in hormone receptor-positive breast cancer: an analysis of the DATA trial.信件回复：管腔样亚型在激素受体阳性乳腺癌中的预后及预测价值：DATA试验分析
ESMO Open. 2025 May;10(5):105066. doi: 10.1016/j.esmoop.2025.105066. Epub 2025 Apr 30.
4
Response to letter re: The prognostic and predictive value of the luminal-like subtype in hormone receptor-positive breast cancer: an analysis of the DATA trial.对关于“激素受体阳性乳腺癌中腔面样亚型的预后和预测价值：DATA试验分析”的信件的回复
ESMO Open. 2025 May;10(5):105068. doi: 10.1016/j.esmoop.2025.105068. Epub 2025 Apr 16.
5
The prognostic and predictive value of the luminal-like subtype in hormone receptor-positive breast cancer: an analysis of the DATA trial.激素受体阳性乳腺癌中腔面样亚型的预后和预测价值：DATA试验分析
ESMO Open. 2025 Feb;10(2):104154. doi: 10.1016/j.esmoop.2025.104154. Epub 2025 Feb 7.
6
Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor-Positive, HER-2 Negative Breast Cancer.孕激素受体亚型在雌激素受体阳性、HER-2 阴性乳腺癌患者中的预后价值。
Oncologist. 2019 Feb;24(2):165-171. doi: 10.1634/theoncologist.2018-0176. Epub 2018 Aug 31.
7
Relationship between functional imaging and immunohistochemical markers and prediction of breast cancer subtype: a PET/MRI study.功能成像与免疫组化标志物与乳腺癌亚型预测的关系：一项 PET/MRI 研究。
Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1680-1693. doi: 10.1007/s00259-018-4010-7. Epub 2018 Apr 25.
8
Comparison of prognostic and predictive impact of genomic or central grade and immunohistochemical subtypes or IHC4 in HR+/HER2- early breast cancer: WSG-AGO EC-Doc Trial.激素受体阳性/人表皮生长因子受体 2 阴性早期乳腺癌中基因组或中央分级及免疫组织化学亚型或 IHC4 对预后和预测影响的比较：WSG-AGO EC-Doc 试验。
Ann Oncol. 2016 Jun;27(6):1035-1040. doi: 10.1093/annonc/mdw070. Epub 2016 Feb 18.
9
A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naïve Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Bevacizumab in Urothelial Cancer.初治尿路上皮癌分子分类中的预后基因表达特征可预测新辅助化疗的临床结局：一项尿路上皮癌剂量密集型甲氨蝶呤、长春碱、阿霉素和顺铂联合贝伐单抗的2期试验
Eur Urol. 2016 May;69(5):855-62. doi: 10.1016/j.eururo.2015.08.034. Epub 2015 Sep 3.
10
Identification of a Low-Risk Luminal A Breast Cancer Cohort That May Not Benefit From Breast Radiotherapy.识别低危管腔 A 型乳腺癌队列，该队列可能不需要接受乳房放疗。
J Clin Oncol. 2015 Jun 20;33(18):2035-40. doi: 10.1200/JCO.2014.57.7999. Epub 2015 May 11.
本文引用的文献
1
The prognostic and predictive value of the luminal-like subtype in hormone receptor-positive breast cancer: an analysis of the DATA trial.激素受体阳性乳腺癌中腔面样亚型的预后和预测价值：DATA试验分析
ESMO Open. 2025 Feb;10(2):104154. doi: 10.1016/j.esmoop.2025.104154. Epub 2025 Feb 7.
2
Extended Adjuvant Endocrine Treatment in Luminal Breast Cancers in the Era of Genomic Tests.激素受体阳性乳腺癌的延长内分泌治疗时代：基于基因检测的新视角
Int J Mol Sci. 2022 Nov 6;23(21):13604. doi: 10.3390/ijms232113604.
3
Targeting HER2-positive breast cancer: advances and future directions.针对 HER2 阳性乳腺癌：进展与未来方向。
Nat Rev Drug Discov. 2023 Feb;22(2):101-126. doi: 10.1038/s41573-022-00579-0. Epub 2022 Nov 7.
4
Toxicity of Extended Adjuvant Therapy With Aromatase Inhibitors in Early Breast Cancer: A Systematic Review and Meta-analysis.早期乳腺癌中延长芳香酶抑制剂辅助治疗的毒性：系统评价和荟萃分析。
J Natl Cancer Inst. 2018 Jan 1;110(1). doi: 10.1093/jnci/djx141.
5
Interobserver Variability of Ki-67 Measurement in Breast Cancer.乳腺癌中Ki-67测量的观察者间差异
J Pathol Transl Med. 2016 Mar;50(2):129-37. doi: 10.4132/jptm.2015.12.24. Epub 2016 Feb 15.
Zotero 插件